ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,440,000 | -13.0% | 1,000,000 | -4.3% | 7.33% | -2.1% |
| Q3 2016 | $14,306,000 | +54.9% | 1,045,000 | -16.4% | 7.49% | +21.3% |
| Q2 2016 | $9,238,000 | +15.6% | 1,250,000 | 0.0% | 6.17% | +23.9% |
| Q1 2016 | $7,988,000 | -2.4% | 1,250,000 | -4.6% | 4.98% | +45.5% |
| Q4 2015 | $8,188,000 | +7.0% | 1,310,000 | 0.0% | 3.42% | -9.1% |
| Q3 2015 | $7,650,000 | -38.3% | 1,310,000 | -12.7% | 3.76% | -23.7% |
| Q2 2015 | $12,405,000 | +0.4% | 1,500,000 | 0.0% | 4.94% | -14.0% |
| Q1 2015 | $12,360,000 | +18.0% | 1,500,000 | -1.6% | 5.74% | +8.4% |
| Q4 2014 | $10,477,000 | -99.9% | 1,525,000 | +1.7% | 5.29% | -16.2% |
| Q3 2014 | $8,100,000,000 | +76503.0% | 1,500,000 | -9.6% | 6.31% | -30.7% |
| Q2 2014 | $10,574,000 | -21.4% | 1,660,000 | -0.6% | 9.12% | -8.3% |
| Q1 2014 | $13,460,000 | -99.9% | 1,670,000 | 0.0% | 9.94% | +6.8% |
| Q4 2013 | $11,857,000,000 | – | 1,670,000 | – | 9.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |